CYCC Bio Green Med Solution Inc.


$ 2.04 $ 0.13 (6.84 %)    

Monday, 27-Oct-2025 11:06:27 EDT
QQQ $ 626.14 $ 0.00 (0 %)
DIA $ 474.09 $ -0.70 (-0.15 %)
SPY $ 682.75 $ -0.02 (-0 %)
TLT $ 91.23 $ -0.08 (-0.09 %)
GLD $ 365.60 $ -5.41 (-1.46 %)
$ 1.84
$ 1.88
$ 2.01 x 200
$ 2.05 x 300
$ 1.88 - $ 2.12
$ 1.73 - $ 102.44
251,817
na
na
$ 1.33
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION